CCND1 and breast carcinoma: Expression of CDK2-AP1, CDK2 and CyclinD1 in 40 cases of normal breast tissues, 30 cases of ductal breast cancer in situ, 121 cases of invasive breast cancer and 18 cases of relapsed breast cancer were examined by immunohistochemical staining.